Milestone Pharma Announces Etripamil Phase 2 Clinical Program Success for the Treatment of PSVT
Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular compan announced positive data from its Phase 2 NODE-1 trial evaluating...